Showing 1 - 13 results of 13 for search '(((( 50 ((_ decrease) OR (mean decrease)) ) OR ( 50 ng decrease ))) OR ( 10 mg decrease ))~', query time: 0.51s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Mutagenesis of the CXCL10 binding site on <i>L</i>. <i>(L</i>.<i>) major</i> GP63 to <i>L</i>. <i>(V</i>.<i>) panamensis</i> residues reduces CXCL10 cleavage and T cell chemotaxis. by Alejandro L. Antonia (7147739)

    Published 2021
    “…(V.) panamensis <i>allele (N463) at the CXCL10 binding site decreases CXCR3</i><sup><i>+</i></sup> <i>T cell chemotaxis</i>. …”
  9. 9

    Minimum concentration of Amphotericin B in serum according to the formulation, dose, and daily or prolonged intermittent therapeutic regimen by Leticia Aparecida Schiave (8438409)

    Published 2020
    “…The geometric mean Cmin tended to decrease with a reduction in the dose and frequency of intermittent L-AmB infusions: 357 ng/mL (100 mg 4 to 5 times/week) > 263 ng/mL (50 mg 4 to 5 times/week) > 227 ng/mL (50 mg 1 to 3 times/week). …”
  10. 10
  11. 11

    DataSheet1_Acute and Long-Term Treatment With Dapagliflozin and Association With Serum Soluble Urokinase Plasminogen Activator Receptor.DOCX by Viktor Rotbain Curovic (9182235)

    Published 2022
    “…In the long-term trial the mean difference was 0.06 ng/ml (95% CI -0.15; 0.27, p = 0.57).…”
  12. 12

    Supplementary Material for: Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism in Hemodialysis Patients in a... by figshare admin karger (2628495)

    Published 2025
    “…These parameters were monitored weekly or biweekly, and 1,25D quarterly. Results: Mean (±SE) serum total 25D rose with ERC treatment from 24.1±1.7 ng/mL at baseline (BL) to steady-state levels of 157.7±10.4 (p<0.001) after 12 weeks, with all individual levels exceeding 50 ng/mL but varying inversely with body weight. …”
  13. 13

    Additional file 2 of Single-cell profiling reveals periosteal signatures of impaired periosteal cells proliferation in a drill-hole model of type 2 diabetes by Xing Ji (3096735)

    Published 2025
    “…Osteoblasts were treated with vehicle or varying concentrations of FGL2 (50, 200 ng/mL) under normal (vehicle) and high glucose (4.5 mg/mL) conditions, and relative cell proliferation was assessed after 48 h to compare the effects under these different conditions. …”